Max India Limited [MAXIND] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Max India Limited wins in 5 metrics, Dr. Agarwal's Eye Hospital Ltd. wins in 13 metrics, with 0 ties. Dr. Agarwal's Eye Hospital Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Max India Limited | Dr. Agarwal's Eye Hospital Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.10 | 34.01 | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Book Ratio | 1.74 | 7.52 | Max India Limited |
| Debt-to-Equity Ratio | 43.62 | 106.45 | Max India Limited |
| PEG Ratio | 0.31 | 1.81 | Max India Limited |
| EV/EBITDA | -5.70 | 20.64 | Dr. Agarwal's Eye Hospital Ltd. |
| Profit Margin (TTM) | -80.64% | 15.50% | Dr. Agarwal's Eye Hospital Ltd. |
| Operating Margin (TTM) | -59.39% | 19.54% | Dr. Agarwal's Eye Hospital Ltd. |
| EBITDA Margin (TTM) | N/A | 19.54% | N/A |
| Return on Equity | -39.14% | 26.07% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Assets (TTM) | -22.18% | 8.91% | Dr. Agarwal's Eye Hospital Ltd. |
| Free Cash Flow (TTM) | $-1.63B | $-83.80M | Dr. Agarwal's Eye Hospital Ltd. |
| Dividend Yield | N/A | 0.11% | N/A |
| 1-Year Return | -17.87% | 12.35% | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Sales Ratio (TTM) | 4.43 | 5.39 | Max India Limited |
| Enterprise Value | $6.63B | $26.69B | Dr. Agarwal's Eye Hospital Ltd. |
| EV/Revenue Ratio | 3.60 | 5.92 | Max India Limited |
| Gross Profit Margin (TTM) | 70.23% | 78.09% | Dr. Agarwal's Eye Hospital Ltd. |
| Revenue per Share (TTM) | $39 | $952 | Dr. Agarwal's Eye Hospital Ltd. |
| Earnings per Share (Diluted) | $-29.75 | $147.68 | Dr. Agarwal's Eye Hospital Ltd. |
| Beta (Stock Volatility) | 0.22 | -0.57 | Dr. Agarwal's Eye Hospital Ltd. |
Max India Limited vs Dr. Agarwal's Eye Hospital Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Max India Limited | 0.11% | 1.71% | -2.06% | 11.53% | -16.59% | -13.59% |
| Dr. Agarwal's Eye Hospital Ltd. | 0.58% | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Max India Limited | -17.87% | 34.79% | 119.60% | 108.47% | 108.47% | 108.47% |
| Dr. Agarwal's Eye Hospital Ltd. | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
Performance & Financial Health Analysis: Max India Limited vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | MAXIND | DRAGARWQ |
|---|---|---|
| Market Information | ||
| Market Cap | ₹8.17B | ₹24.28B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 50,115 | 1,256 |
| 90 Day Avg. Volume | 54,580 | 1,378 |
| Last Close | ₹158.62 | ₹4,991.20 |
| 52 Week Range | ₹120.00 - ₹241.57 | ₹4,142.00 - ₹6,392.00 |
| % from 52W High | -34.34% | -21.91% |
| All-Time High | ₹338.00 (Jul 08, 2024) | ₹7,300.00 (Dec 30, 2024) |
| % from All-Time High | -53.07% | -31.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.27% | 0.22% |
| Quarterly Earnings Growth | N/A | 0.66% |
| Financial Health | ||
| Profit Margin (TTM) | -0.81% | 0.16% |
| Operating Margin (TTM) | -0.59% | 0.20% |
| Return on Equity (TTM) | -0.39% | 0.26% |
| Debt to Equity (MRQ) | 43.62 | 106.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹89.40 | ₹668.22 |
| Cash per Share (MRQ) | ₹68.03 | ₹191.98 |
| Operating Cash Flow (TTM) | ₹-1,558,828,000 | ₹738.70M |
| Levered Free Cash Flow (TTM) | ₹-1,403,920,000 | ₹546.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.11% |
| Last 12-Month Dividend | N/A | ₹5.00 |
Valuation & Enterprise Metrics Analysis: Max India Limited vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | MAXIND (Apr 24, 2026) | DRAGARWQ (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.10 | 34.01 |
| Forward P/E | N/A | 516.77 |
| PEG Ratio | 0.31 | 1.81 |
| Price to Sales (TTM) | 4.43 | 5.39 |
| Price to Book (MRQ) | 1.74 | 7.52 |
| Market Capitalization | ||
| Market Capitalization | ₹8.17B | ₹24.28B |
| Enterprise Value | ₹6.63B | ₹26.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.60 | 5.92 |
| Enterprise to EBITDA | -5.70 | 20.64 |
| Risk & Other Metrics | ||
| Beta | 0.22 | -0.57 |
| Book Value per Share (MRQ) | ₹89.40 | ₹668.22 |
Financial Statements Comparison: Max India Limited vs Dr. Agarwal's Eye Hospital Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MAXIND (2025) | DRAGARWQ (2025) |
|---|---|---|
| Revenue/Sales | 1.45B | 3.94B |
| Cost of Goods Sold | 363.41M | 896.20M |
| COGS % of Revenue | 25.0% | 22.8% |
| Gross Profit | 1.09B | 3.04B |
| Gross Margin | 75.0% | 77.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -1.34B | 813.30M |
| Operating Margin | -92.2% | 20.6% |
| EBITDA | -973.77M | 1.22B |
| EBITDA Margin | -66.9% | 31.1% |
| Pre-Tax Income | -1.39B | 707.00M |
| Pre-Tax Income % of Revenue | -95.3% | 17.9% |
| Income Tax | 18.11M | 160.50M |
| Income Tax % of Revenue | 1.2% | 4.1% |
| Net Income (Profit) | -1.40B | 546.50M |
| Profit Margin | -96.5% | 13.9% |
Balance Sheet & Liquidity Metrics
| Metric | MAXIND (2025) | DRAGARWQ (2025) |
|---|---|---|
| Cash & Equivalents | 226.95M | 111.60M |
| Total Current Assets | 2.61B | 559.40M |
| Total Current Assets % of Revenue | 179.1% | 14.2% |
| Total Current Liabilities | 1.65B | 869.80M |
| Total Current Liabilities % of Revenue | 113.6% | 22.1% |
| Long-Term Debt | 958.90M | 3.06B |
| Long-Term Debt % of Revenue | 65.9% | 77.6% |
| Total Shareholders Equity | 3.59B | 2.10B |
| Retained Earnings | -2.24B | 1.99B |
| Retained Earnings % of Revenue | -154.2% | 50.4% |
| Property, Plant & Equipment | 1.53B | 1.37B |
Cash Flow Statement Comparison
| Metric | MAXIND (2025) | DRAGARWQ (2025) |
|---|---|---|
| Operating Cash Flow | -1.56B | 738.70M |
| Operating Cash Flow % of Revenue | -107.1% | 18.8% |
| Capital Expenditures | -354.06M | 4.10M |
| Free Cash Flow | -1.63B | -83.80M |
| FCF Margin | -112.4% | -2.1% |
| Debt Repayment | N/A | -111.30M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MAXIND | DRAGARWQ |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 52.52M | 4.83M |
| Float Shares | 24.68M | 1.08M |
| % Held by Insiders | 59.61% | 77.59% |
| % Held by Institutions | 0.07% | 3.57% |
| % Held by Public | 40.32% | 18.84% |
Dividend Analysis & Yield Comparison: Max India Limited vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | MAXIND | DRAGARWQ |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹5.00 |
| Last 12-Month Dividend Yield | N/A | 0.11% |
| 3-Year Avg Annual Dividend | N/A | ₹4.50 |
| 3-Year Avg Dividend Yield | N/A | 0.12% |
| 3-Year Total Dividends | N/A | ₹13.50 |
| Ex-Dividend Date | N/A | Nov 08, 2024 |